RhumbLine Advisers’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $582K | Buy |
106,402
+15,920
| +18% | +$87.1K | ﹤0.01% | 2592 |
|
|
2025
Q1 | $569K | Buy |
90,482
+10,608
| +13% | +$66.7K | ﹤0.01% | 2491 |
|
|
2024
Q4 | $329K | Sell |
79,874
-2,097
| -3% | -$8.64K | ﹤0.01% | 2938 |
|
|
2024
Q3 | $274K | Buy |
81,971
+6,753
| +9% | +$22.6K | ﹤0.01% | 3071 |
|
|
2024
Q2 | $224K | Buy |
75,218
+23,263
| +45% | +$69.3K | ﹤0.01% | 3164 |
|
|
2024
Q1 | $179K | Buy |
51,955
+491
| +1% | +$1.69K | ﹤0.01% | 3231 |
|
|
2023
Q4 | $69K | Sell |
51,464
-2,808
| -5% | -$3.76K | ﹤0.01% | 3557 |
|
|
2023
Q3 | $118K | Buy |
54,272
+4,215
| +8% | +$9.19K | ﹤0.01% | 3404 |
|
|
2023
Q2 | $120K | Buy |
+50,057
| New | +$120K | ﹤0.01% | 3450 |
|